PCN79 COST EFFECTIVENESS OF OSIMERTINIB VERSUS CHEMOTHERAPY...

Value in Health 2019 / 05 Vol. 22

PCN79 COST EFFECTIVENESS OF OSIMERTINIB VERSUS CHEMOTHERAPY IN SECOND LINE TREATMENT OF NON SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR AND 790M MUTATION IN CHILEAN HEALTH SYSTEM

Rojas, R., Balmaceda, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.203
Date:
May, 2019
File:
PDF, 381 KB
english, 2019
Conversion to is in progress
Conversion to is failed